Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia [EARLY_Phase 1]

View source ↗

Summary

This entry notes an early Phase 1 trial at Peking University testing adjunctive thyroxine for avolition in schizophrenia, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Peking University | Conditions: Schizophrenia, Avolition | EARLY_Phase 1 | Status: NOT_YET_RECRUITING